Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01884961Phase 2Completed
Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2
Malignant Melanoma, MetastaticMetastatic Renal Cell Cancer
PrincipalinvestigatorStart date: 2012-07-09

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

IRST IRCCS, Meldola

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jinwan Wang, M.D

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related
2 trials

Shared therapeutic areas:

Metastatic Renal Cell Cancer
Similarity Score15%

Jacek Pinski, MD

University of Southern California

Related
6 trials

Shared therapeutic areas:

Metastatic Renal Cell Cancer
Similarity Score15%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic Renal Cell Cancer
Similarity Score15%

Christine CHEVREAU, MD

IUCT-O

Related
1 trials

Shared therapeutic areas:

Metastatic Renal Cell Cancer
Similarity Score15%

Jennifer Johnson, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Metastatic Renal Cell Cancer
Similarity Score15%

Padmanee Sharma

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Metastatic Renal Cell Cancer
Similarity Score15%

antoine thiery-vuillemin, MD PhD

Centre Hospitalier Universitaire de Besancon

Related
1 trials

Shared therapeutic areas:

Metastatic Renal Cell Cancer
Similarity Score15%

Ely Benaim, MD

Rexahn Pharmaceuticals, Inc.

Related
4 trials

Shared therapeutic areas:

Metastatic Renal Cell Cancer
Similarity Score15%

Inge Marie Svane, Prof., MD

CCIT (Center for Cancer Immune Therapy)

Related
1 trials

Shared therapeutic areas:

Malignant Melanoma, Metastatic
Similarity Score15%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
12 trials

Shared therapeutic areas:

Metastatic Renal Cell Cancer
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01884961Phase 2PrincipalInvestigator

Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2

Malignant Melanoma, MetastaticMetastatic Renal Cell Cancer
Completed

All 1 trials loaded